Biomedical Engineering Reference
In-Depth Information
49. Gagnon C, Sims NA, Mumm S, McAuley SA, Jung C, Poulton
IJ, J.Clin. Endocrinol. Metabol. (2010) Lack of sustained
response to teriparatide in a patient with adult hypophospha-
tasia. J.Clin. Endocrinol. Metabol. 95, 1007-1012.
50. Vahle JL, Long GG, Sandusky G, Westmore M, Ma YL, Sato
M. (2004) Bone neoplasms in F344 rats given teriparatide
[rhPTH(1-34)] are dependent on duration of treatment and
dose. Toxicol. Pathol. 32, 426-438.
51. Modulators of sclerostin binding partners for treating bone
related disorders. Patent no. WO 2008/092894 A1, published
Aug 7, 2008.
52. Chung TDY, Sergienko E, Millan JL. (2010) Assay format as a
critical success factor for identification of novel inhibitor
chemotypes of tissue-nonspecific alkaline phosphatase from
high-throughput screening. Molecules 15, 3010-3037.
53. Hessle L, Johnsson KA, Anderson HC, Narisawa S, Sali A,
et al. (2002) Tissue-nonspecific alkaline phosphatase and
plasma cell membrane glycoprotein-1 are central antagonistic
regulators of bone mineralization. Proc. Natl. Acad. Sci. USA.
99, 9445-9449.
54. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R,
Millan JL. (2004) Concerted regulation of inorganic pyro-
phosphate and osteopontin by Akp2, Enpp1, and Ank: an
integrated model of the pathogenesis of mineralization disor-
ders. Am. J. Pathol. 164, 1199-1209.
55. Anderson HC, Harmey D, Camacho NP, Garimella R, Sipe JB,
Tague S, et al. (2005) Sustained osteomalacia of long bones
despite major improvement in other hypophosphatasia-related
mineral deficits in tissue nonspecific alkaline phosphata-
se/nucleotide pyrophosphatase phosphodiesterase 1 double-
deficient mice. Am. J. Pathol. 66, 1711-1720.
56. Yamamoto S, Orimo H, Matsumoto T, Iijima O, Narisawa S,
Maeda T, et al. (2011) Prolonged survival and phenotypic
correction of Akp2(
/
) hypophosphatasia mice by lentiviral
gene therapy. J. Bone Miner. Res. 26, 135-142.
57. Matsumoto T, Yamamoto S, Iijima O, Orimo H, Miyake K,
Miyake N, et al. (2011) Rescue of severe infantile hypophos-
phatasiaMice by AAV-mediated sustained expression of soluble
alkaline phosphatase. Hum. Gene Ther. 22, 1355-1364.
58. Hanawa H, Yamamoto M, Zhao H, Shimada T, Persons DA.
(2009) Optimized lentiviral vector design improves titer
and
chicken beta-globin locus HS4 insulator element. Mol. Ther.
17, 667-674.
59. Nienhuis AW, Dunbar CE, Sorrentino BP. (2006) Genotoxicity
of retroviral integration in hematopoietic cells. Mol. Ther. 13,
1031-1049.
60. Hanawa H, Hargrove PW, Kepes S, Srivastava DK, Nienhuis
AW, Persons DA. (2004) Extended beta-globin locus control
region elements promote consistent therapeutic expression of a
gamma-globin lentiviral vector in murine beta-thalassemia.
Blood 104, 2281-2290.
61. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G,
Schmidt M, Kutschera I, et al. (2009) Hematopoietic stem cell
gene therapy with a lentiviral vector in X-linked adrenoleuko-
dystrophy. Science 326, 818-823.
62. Kaiser J. (2009) Gene therapy. Beta-thalassemia treatment
succeeds, with a caveat. Science 326, 1468-1469.
63. Jarraya B, Boulet S, Ralph GS, Jan C, Bonvento G, Azzouz M,
et al. (2009) Dopamine gene therapy for Parkinson's disease in
a nonhuman primate without associated dyskinesia. Sci.
Transl. Med. 1(2), 2ra4.
64. Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko
JJ, et al. (2006) Successful transduction of liver in hemophilia
by AAV-Factor IX and limitations imposed by the host immune
response. Nat. Med. 12, 342-347.
65. Passini MA, Bu J, Fidler JA, Ziegler RJ, Foley JW, Dodge JC,
et al. (2007) Combination brain and systemic injections of
AAV provide maximal functional and survival benefits in
the Niemann-Pick mouse. Proc. Natl. Acad. Sci. USA. 104,
9505-9510.
66. Kurai T, Hisayasu S, Kitagawa R, Migita M, Suzuki H, Hirai Y,
et al. (2007) AAV1 mediated co-expression of formylglycine-
generating enzyme and arylsulfatase a efficiently corrects
sulfatide storage in a mouse model of metachromatic leuko-
dystrophy. Mol. Ther. 15, 38-43.
67. Ogawa K, Hirai Y, Ishizaki M, Takahashi H, Hanawa H,
Fukunaga Y, et al. (2009) Long-term inhibition of glycosphin-
golipid accumulation in Fabry model mice by a single systemic
injection of AAV1 vector in the neonatal period. Mol. Genet.
Metab. 96, 91-96.
68. Jaroszewski L, Rychlewski L, Li Z, Li W, Godzik A (2005)
FFAS03: a server for profile-profile sequence alignments.
Nucleic Acids Res. 33, W284-W288.
transgene
expression
of
vectors
containing
the
Search WWH ::
Custom Search